Skip to main content
. 2018 Sep 20;10(4):163. doi: 10.3390/pharmaceutics10040163

Figure 4.

Figure 4

The effect of CPEs in Pal-GH gel formulations on the MTZ release (A) and skin permeation (B) profiles. Significant differences in MTZ release were observed among all formulations except between F5MTZ and F5IPM-MTZ (* p < 0.05), and in MTZ permeation between F5PG-MTZ and F5EtOH-MTZ or F5TRANS-MTZ; and between F5IPM-MTZ and F5EtOH-MTZ or F5TRANS-MTZ (* p < 0.05). Symbols: ■: F5PG-MTZ, ●: F5IPM-MTZ, ▲: F5MTZ, ◆: F5DMSO-MTZ, ◇: F5EtOH-MTZ, ○: F5TRANS-MTZ (Mean ± S.E., n = 3–4).